Home

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P

CIK 1276801 · last filed 2009-12-10

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $999.9K of ZIOP on Dec 10, 2009. Across all open-market trades the lifetime net is +$10.2M, making them a net buyer over the disclosed history. The firm reports its address in The Woodlands, TX. 5 SEC filings were submitted jointly with PHARMACEUTICAL CO LA JOLLA.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

6

Lifetime Open-Market Net

$10.20M

Filer Profile

Reported Address
21 WATERWAY AVENUE
SUITE 225
THE WOODLANDS, TX 77380
Phone
(281) 364-8338
Related Filers
PHARMACEUTICAL CO LA JOLLA — 5 joint filings, latest 2009-08-07
Essex Woodlands Health Ventures VI, LLC — 2 joint filings, latest 2007-11-14
ABIOMED INC — 1 joint filings, latest 2011-12-29
ESSEX WOODLANDS HEALTH VENTURES FUND V LP — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A LP — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VIII-B LP — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Alaunos Therapeutics, Inc. (ZIOP) Delisted 10%+ Owner 2,371,642 $0.87 $2.05M $999.9K 2 2009-12-10
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted 10%+ Owner 0 $6.22 $0 $9.20M 4 2009-08-07

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2009-12-10 Alaunos Therapeutics, Inc. (ZIOP) Delisted Buy (P) +457,766 $999.9K EDGAR
2009-08-07 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Sell (S) −1,161,814 -$216.1K EDGAR
2009-02-26 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Sell (S) −8,586,830 -$517.4K EDGAR
2008-05-14 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Buy (P) +2,081,977 $3.93M EDGAR
2007-04-12 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Buy (P) +1,000,000 $6.00M EDGAR
2007-02-23 Alaunos Therapeutics, Inc. (ZIOP) Delisted Mixed +1,913,876 $10.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.